The U.S. Meals and Drug Administration (FDA) authorized Poherdy (pertuzumab-dpzb) as the primary interchangeable biosimilar to Perjeta (pertuzumab) for sufferers with HER2-positive...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for...
